Maternal smoking during pregnancy and genetic polymorphisms in the Ah receptor, CYP1A1 and GSTM1 affect infant birth size in Japanese subjects

Molecular Human Reproduction

Volumn 12, Issue 2, 2006, Pages 77-83

  Sasaki, S ^a   Kondo, T ^a   Sata, F ^a   Saijo, Y ^a   Katoh, S ^a   Nakajima, S ^a   Ishizuka, M ^b   Fujita, S ^b   Kishi, R ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Ah receptor; CYP1A1; Fetal development; GSTM1; Maternal smoking

Indexed keywords

ARGININE; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1;

ADULT; ARTICLE; BODY HEIGHT; BODY SIZE; CHILDBIRTH; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DELIVERY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFANT; JAPAN; LOW BIRTH WEIGHT; MALE; MATERNAL BEHAVIOR; NULL ALLELE; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; WILD TYPE;

ADULT; BODY HEIGHT; BODY WEIGHT; COHORT STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; INFANT, NEWBORN; JAPAN; MALE; POLYMORPHISM, GENETIC; PREGNANCY; PROSPECTIVE STUDIES; RECEPTORS, ARYL HYDROCARBON; SMOKING;

NICOTIANA TABACUM;

EID: 33645530358     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gal013     Document Type: Article

References (47)

1. Anttila S, Tuominen P, Hirvonen A, Nurminen M, Karjalainen A, Hankinson O and Elovaara E (2001) CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor. Pharmacogenetics 11,501-509.
2. Bush PG, Mayhew TM, Abramovich DR, Aggett PJ, Burke MD and Page KR (2000) Maternal cigarette smoking and oxygen diffusion across the placenta. Placenta 21,824-833.
3. Cauchi S, Stücker I, Solas C, Laurent-Puig P, Cénée S, Hémon D, Jacquet M, Kremers P, Beaune P and Massaad-Massade L (2001) Polymorphisms of human aryl hydrocarbon receptor (AhR) gene in a French population: Relationship with CYP1A1 inducibility and lung cancer. Carcinogenesis 22,1819-1824.
4. Chen S, Xue K, Xu L, Ma G and Wu J (2001) Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population. Mutat Res 458,41-47.
5. Citizens Survey on Maternal and Child Health (2001) Health & Welfare Bureau, Sapporo City (in Japanese).
6. Cliver SP, Goldenberg RL, Cutter GR, Hoffman HJ, Davis RO and Nelson KG (1995) The effect of cigarette smoking on neonatal anthropometric measurements. Obstet Gynecol 85,625-630.
7. Cnattingius S (2004) The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res 6,S125-S140.
8. England LJ, Kendrick JS, Gargiullo PM, Zahniser SC and Hannon WH (2001a) Measures of maternal tobacco exposure and infant birth weight at term. Am J Epidemiol 153,954-960.
9. England LJ, Kendrick JS, Wilson HG, Merritt RK, Gargiullo PM and Zahniser SC (2001b) Effects of smoking reduction during pregnancy on the birth weight of term infants. Am J Epidemiol 154,694-701.
10. Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM and Gonzalez FJ (1996) Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol 140,173-179.
11. Goldman R, Enewold L, Pellizzari E, Beach JB, Bowman ED, Krishnan SS and Shields PG (2001) Smoking increases carcinogenic polycyclic aromatic hydrocarbons in human lung tissue. Cancer Res 61,6367-6371.
12. Harper PA, Wong JMY, Lam MSM and Okey AB (2002) Polymorphisms in the human AH receptor. Chem Biol Interact 141,161-187.
13. Haug K, Irgens LM, Skjaerven R, Markestad T, Baste V and Schreuder P (2000) Maternal smoking and birthweight: Effect modification of period, maternal age and paternal smoking. Acta Obstet Gynecol Scand 79,485-489.
14. Hayes JD and Strange RC (2000) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61,154-166.
15. Inoue H, Kiyohara C, Shinomiya S, Marugame T, Tsuji E, Hanada K, Hayabuchi H, Eguchi H, Fukushima Y and Kono S (2001) Glutathione S-transferase polymorphisms and risk of colorectal adenomas. Cancer Lett 163,201-206.
16. Jauniaux E, Biernaux V, Gerlo E and Gulbis B (2001) Chronic maternal smoking and cord blood amino acid and enzyme levels at term. Obstet Gynecol 97,57-61.
17. Källén K (2001) The impact of maternal smoking during pregnancy on delivery outcome. Eur J Public Health 11,329-333.
18. Kawajiri K, Watanabe J, Eguchi H, Nakachi K, Kiyohara C and Hayashi S (1995) Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenetics 5,151-158.
19. Kihara M, Kihara M and Noda K (1995) Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 16,2331-2336.
20. Kihara M, Kihara M and Noda K (1999) Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers. Cancer Lett 137,53-60.
21. Komiya Y, Tsukino H, Nakao H, Kuroda Y, Imai H and Katoh T (2005) Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J Cancer Res Clin Oncol 131,238-242.
22. Kurahashi N, Sata F, Kasai S, Shibata T, Moriya K, Yamada H, Kakizaki H, Minakami H, Nonomura K and Kishi R (2005) Maternal genetic polymorphisms in CYP1A1, GSTM1 and GSTT1 and the risk of hypospadias. Mol Hum Reprod 11,93-98.
23. Lieberman E, Gremy I, Lang JM and Cohen AP (1994) Low birthweight at term and the timing of fetal exposure to maternal smoking. Am J Public Health 84,1127-1131.
24. Lin P, Hu SW and Chang TH (2003) Correlation between gene expression of aryl hydrocarbon receptor (AhR), hydrocarbon receptor nuclear translocator (Arnt), cytochromes P4501A1 (CYP1A1) and 1B1 (CYP1B1), and inducibility of CYP1A1 and CYP1A1 in human lymphocytes. Toxicol Sci 71,20-26.
25. Ma M, Umemura T, Mori Y, Gong Y, Saijo Y, Sata F, Kawai T and Kishi R (2005) Influence of genetic polymorphisms of styrene-metabolizing enzymes and smoking habits on levels of urinary metabolites after occupational exposure to styrene. Toxicol Lett 160,84-91.
26. Munaka M, Kohshi K, Kawamoto T, Takasawa S, Nagata N, Itoh H, Oda S and Katoh T (2003) Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma. J Cancer Res Clin Oncol 129,355-360.
27. Murata M, Watanabe M, Yamanaka M, Kubota Y, Ito H, Nagao M, Katoh T, Kamataki T, Kawamura J, Yatani R et al. (2001) Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett 165,171-177.
28. Nakachi K, Imai K, Hayashi S and Kawajiri K (1993) Polymorphisms of the CYP1A1 and glutathione S-Transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res 53,2994-2999.
29. Nukui T, Day RD, Sims CS, Ness RB and Romkes M (2004) Maternal/newborn GSTT1 null genotype contributes to risk of preterm, low birthweight infants. Pharmacogenetics 14,569-576.
30. Ohmi H, Hirooka K and Mochizuki Y (2002) Fetal growth and the timing of exposure to maternal smoking. Pediatr Int 44,55-59.
31. Perera FP, Whyatt RM, Jedrychowski W, Rauh V, Manchester D, Santella R and Ottman R (1998) Recent developments in molecular epidemiology: A study of the effects of environmental polycyclic aromatic hydrocarbons on birth outcomes in Poland. Am J Epidemiol 147,309-314.
32. Perera FP, Jedrychowski W, Rauh V and Whyatt RM (1999) Molecular epidemiologic research on the effects of environmental pollutants on the fetus. Environ Health Perspect 107,451-460.
33. Perera FP, Rauh V, Whyatt RM, Tsai WY, Bernert JT, Tu YH, Andrews H, Ramirez J, Qu L and Tang D (2004) Molecular evidence of an interaction between prenatal environmental exposures and birth outcomes in a multiethnic population. Environ Health Perspect 112,626-630.
34. Saijo Y, Sata F, Yamada H, Suzuki K, Sasaki S, Kondo T, Gong Y, Kato EH, Shimada S, Morikawa M et al. (2004) Ah receptor, CYP1A1, CYP1A2 and CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss. Mol Hum Reprod 10,729-733.
35. Sata F, Yamada H, Kondo T, Gong Y, Tozaki S, Kobashi G, Kato EH, Fujimoto S and Kishi R (2003) Glutathione S-transferase M1 and T1 polymorphisms and the risk of recurrent pregnancy loss. Mol Hum Reprod 9,165-169.
36. Schneider J, Bernges U, Philipp M and Woitowitz HJ (2004) GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett 208,65-74.
37. Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, Mimura J, Fujii-Kuriyama Y and Ishikawa T (2000) Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci USA 97,779-782.
38. Smith GBJ, Harper PA, Wong JMY, Lam MSM, Reid KR, Petsikas D and Massey TE (2001) Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, Aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms. Cancer Epidemiol Biomarkers Prev 10,839-853.
39. Stücker I, Jacquet M, de Waziers I, Cénée S, Beaune P, Kremers P and Hémon D (2000) Relation between inducibility of CYP1A1, GSTM1 and lung cancer in a French population. Pharmacogenetics 10,617-627.
40. Stücker I, Hirvonen A, de Waziers I, Cabelguenne A, Mitrunen K, Cénée S, Koum-Besson E, Hémon D, Beaune P and Loriot MA (2002) Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis 23,1475-1481.
41. Thurmond TS, Silverstone AE, Baggs RB, Quimby FW, Staples JE and Gasiewicz TA (1999) A chimeric aryl hydrocarbon receptor knockout mouse model indicates that aryl hydrocarbon receptor activation in hematopoietic cells contributes to the hepatic lesions induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 158,33-40.
42. Wang X, Zuckerman B, Pearson C, Kaufman G, Chen C, Wang G, Niu T, Wise PH, Bauchner H and Xu X (2002) Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 287,195-202.
43. Wang J, Deng Y, Cheng J, Ding J and Tokudome S (2003) GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett 201,185-193.
44. Whyatt RM, Santella RM, Jedrychowski W, Garte SJ, Bell DA, Ottman R, Gladek-Yarborough A, Cosma G, Young TL, Cooper TB et al. (1998) Relationship between ambient air pollution and DNA damage in Polish mothers and newborns. Environ Health Perspect 106,821-826.
45. Windham GC, Hopkins B, Fenster L and Swan SH (2000) Prenatal active or passive tobacco smoke exposure and the risk of preterm delivery or low birth weight. Epidemiology 11,427-433.
46. Wong JMY, Harper PA, Meyer UA, Bock KW, Mörike K, Lagueux J, Ayotte P, Tyndale RF, Sellers EM, Manchester DK et al. (2001a) Ethnic variability in the allelic distribution of human aryl hydrocarbon receptor codon 554 and assessment of variant receptor function in vitro. Pharmacogenetics 11,85-94.
47. Wong JMY, Okey AB and Harper PA (2001b) Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction. Biochem Biophys Res Commun 288,990-996.